Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
To investigate the effect of the P-gp inducer rifampicin on the pharmacokinetic parameters of nintedanib
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
26 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal